CS logo
small CS logo
National Hospital Organization Hirosaki National Hospital

Hirosaki, Aomori, Japan
General hospital in Hirosaki
1 Tominocho, Hirosaki, Aomori 036-8545

About National Hospital Organization Hirosaki National Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at National Hospital Organization Hirosaki National Hospital


During the past decade, National Hospital Organization Hirosaki National Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "National Hospital Organization Hirosaki National Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Shire" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Hirosaki National Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at National Hospital Organization Hirosaki National Hospital


According to Clinical.Site data, the most researched conditions in "National Hospital Organization Hirosaki National Hospital" are "Ulcerative Colitis" (8 trials), "Crohn's Disease" (4 trials), "Respiratory Syncytial Virus Infections" (2 trials), "Colitis, Ulcerative" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "National Hospital Organization Hirosaki National Hospital" in a lesser frequency.

Clinical Trials Intervention Types at National Hospital Organization Hirosaki National Hospital


Most popular intervention types in "National Hospital Organization Hirosaki National Hospital" are "Drug" (17 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Guselkumab" (4 trials), "Mirikizumab" (3 trials), "Golimumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

Clinical Trials Genders at National Hospital Organization Hirosaki National Hospital


The vast majority of trials in "National Hospital Organization Hirosaki National Hospital" are 17 trials for "All" genders.

Clinical Trials Status at National Hospital Organization Hirosaki National Hospital


Currently, there are NaN active trials in "National Hospital Organization Hirosaki National Hospital". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in National Hospital Organization Hirosaki National Hospital, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Hirosaki National Hospital, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".